Forever chemicals" or per- and polyfluoroalkyl substances (PFAS) have been widely used in consumer and industrial products for the better part of a ...

Industry veteran Catherine Owen Adams expects external innovation will be key to getting the brain-focused drug developer to “the next level.” ...

Healthy eating, such as less evening eating, predicted higher dream recall, while unhealthy eating—including gastric symptoms ...

Nineteen patients with drug-resistant epilepsy experienced seizure freedom after cannabis oil treatment, with a median ...

A team of researchers from the MIT Sloan School of Management, the Sean M. Healey & AMG Center for ALS at Massachusetts ...

Medtronic's growth strategies, dividend stability, and innovation focus amidst debt concerns and market risks. Click here to ...

Alto Neuroscience Announces Acquisition of Novel Dopamine Agonist Combination Product Candidate, Adding Late-Stage Readout in Treatment Resistant Depression Within Current Cash Runway – ALTO-207 ...

People who can no longer move or speak may soon have a new option: an implanted device that links their brain to a computer.

Sora's FDA clearance of Cirrus simplifies fMRI generation of eloquent cortex maps for surgical planning. MINNEAPOLIS, MN, UNITED STATES, June ...

In cooperation with AbbVie, the global biopharmaceutical research and development company ...

ISTELive25 was another energetic and inspiring conference, held in San Antonio this year with hundreds of sessions and ...

Jazz Pharmaceuticals faced a challenging first quarter as revenue remained flat year over year, missing Wall Street expectations. Management attributed the performance to contrasting trends across its ...